SHENZHEN LBTEK TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN LBTEK TECHNOLOGY CO., LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EMOEWA. The owner is based in SHENZHEN.
2103, BLOCK A, BUILDING 6, SHENZHEN
INTERNATIONAL, INNOVATION VALLEY, XILI COMMUNITY, XILI STREET, NANSHAN DISTRICT,
SHENZHEN , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN LBTEK TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SHENZHEN LBTEK TECHNOLOGY CO., LTD. have?
SHENZHEN LBTEK TECHNOLOGY CO., LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does SHENZHEN LBTEK TECHNOLOGY CO., LTD. file in?
SHENZHEN LBTEK TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SHENZHEN LBTEK TECHNOLOGY CO., LTD.'s most well-known trademarks?
SHENZHEN LBTEK TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as EMOEWA. These are among 4 currently registered trademarks in the portfolio.
What is SHENZHEN LBTEK TECHNOLOGY CO., LTD.'s trademark registration success rate?
SHENZHEN LBTEK TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.